Clayton D D - OmicsDI

Show results for

Unknown (2528)
Transcriptomics (55)
Proteomics (51)
Genomics (24)
Metabolomics (5)
Models (1)
Genomic (1)

Organisms

Homo sapiens (59)
Trypanosoma brucei (17)
Mus musculus (14)
Trypanosoma brucei brucei (8)
Arabidopsis thaliana (4)
Taeniopygia guttata (3)
Saccharomyces cerevisiae (3)
Rattus norvegicus (3)
Drosophila hawaiiensis (1)
Heliothis virescens (1)
Brucella suis 1330 (1)
Loxia curvirostra (1)
Sturnus vulgaris (1)
Aspergillus flavus (1)
Pan troglodytes (1)
Trypanosoma brucei brucei TREU927 (1)
Streptococcus pyogenes (1)
Yersinia pestis (1)
Escherichia coli (1)
Acidianus brierleyi (1)
Klebsiella phage ST405-OXA48phi1.1 (1)
Mustela putorius furo (1)
Pasteurella multocida (1)
Pasteurella multocida subsp. multocida str. Pm70 (1)
Pteropus alecto (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 (1)
Staphylococcus aureus (1)

Organisms

Drosophila melanogaster (1)

Repository

biostudies-arrayexpress (58)
pride (48)
EGA (20)
MetaboLights (5)
BioModels (1)
dbGaP (1)
jPOST (1)
MassIVE (1)
PanoramaPublic (1)
ENA (1)

Tissue

Cell culture (18)
Epithelial cell (4)
Permanent cell line cell (4)
Blood plasma (2)
Colon (2)
Kidney (2)
Leukocyte (2)
Liver (2)
Macrophage (2)
B cell (1)
Blood cell (1)
Bone marrow (1)
Brain (1)
Breast (1)
Cell suspension culture (1)
Embryonic stem cell (1)
Fibroblast (1)
Lung (1)
Malignant cell (1)
Melanocyte (1)
Myoblast (1)
Pancreas (1)
T cell (1)
Testis (1)

Disease

Breast cancer (3)
Pancreatic ductal adenocarcinoma (2)
Warburg micro syndrome (2)
Acute lymphoblastic leukemia (1)
Control (1)
Disease free (1)
Fibrolamellar carcinoma (1)
Neuroblastoma (1)
Prostate adenocarcinoma (1)
Skin melanoma (1)
Thrombocytopenia (1)
Type 1 diabetes mellitus (1)
Warburg micro syndrome 4 (1)

Technology Type

Mass Spectrometry (48)
Shotgun proteomics (28)
Illumina 15K (8)
Affinity purification coupled with mass spectrometry proteomics (8)
Bottom-up proteomics (6)
Data-independent acquisition (6)
DiaPASEF (4)
Mass spectrometry (3)
All-ion fragmentation (2)
Gel-based experiment (2)
Immunopeptidomics (2)
SWATH MS (2)
Illumina HumanHap 550 (1)
Mass spectrometry assay (1)
NMR spectroscopy (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Data-dependent acquisition (1)
SRM/MRM (1)

Instrument Platform

Illumina HiSeq 2000 (7)
NextSeq 500 (6)
Illumina MiSeq (2)
Illumina Genome analyzer IIx (1)
GeneChip Scanner 3000 [Affymetrix] (1)
Illumina Genome Analyzer IIx (1)
ScanArray 4000XL [PerkinElmer] (1)
NextSeq 550 (1)
Orbitrap Fusion Lumos (1)
Direct infusion MS - negative (1)
Direct infusion MS - positive (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2021 (13)
2026 (12)
2024 (10)
2020 (7)
2016 (7)
2010 (7)
2022 (6)
2019 (6)
2018 (6)
2012 (6)
2023 (6)
2017 (5)
2011 (5)
2008 (5)
2013 (4)
2009 (3)
2007 (3)
2015 (2)
2025 (2)

CHEBI ID

CHEBI:10284 (2)
CHEBI:1113 (2)
CHEBI:132502 (2)
CHEBI:14314 (2)
CHEBI:15741 (2)
CHEBI:16027 (2)
CHEBI:16179 (2)
CHEBI:1643 (2)
CHEBI:17306 (2)
CHEBI:17750 (2)
CHEBI:20607 (2)
CHEBI:15361 (1)
CHEBI:15422 (1)
CHEBI:15846 (1)
CHEBI:15978 (1)
CHEBI:16001 (1)
CHEBI:16084 (1)
CHEBI:16108 (1)
CHEBI:16761 (1)
CHEBI:16908 (1)
CHEBI:17234 (1)
CHEBI:17665 (1)
CHEBI:17754 (1)
CHEBI:17794 (1)
CHEBI:17835 (1)
CHEBI:18021 (1)
CHEBI:28013 (1)
CHEBI:29052 (1)
CHEBI:32816 (1)
CHEBI:35780 (1)

Metabolite Name

(-)-Camphor (2)
(E)-3,7-Dimethylocta-1,6-diene-3,8-diol (2)
(R)-2-Hydroxyglutarate (2)
(R)-3-Amino-2-methylpropanoate (2)
(S)-1-Pyrroline-5-carboxylate (2)
(S)-2-Acetolactate (2)
(S)-3-Methyl-2-oxopentanoic acid (2)
(S)-Malate (2)
(Z)-4-Hydroxyphenylacetaldehyde-oxime (2)
1,6,6-Trimethyl-2,7-dioxabicyclo[3.2.2]nonan-3-one (2)
1,8-Diazacyclotetradecane-2,9-dione (2)
1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide (2)
1-Pyrroline-2-carboxylate (2)
1-Pyrroline-4-hydroxy-2-carboxylate (2)
2(alpha-D-Mannosyl)-D-glycerate (2)
2,5-Dioxopentanoate (2)
2,7-Anhydro-alpha-N-acetylneuraminic acid (2)
2-Acetolactate (2)
2-Aminobutan-4-olide (2)
2-C-Methyl-D-erythritol 4-phosphate (2)
2-Dehydro-D-xylonate (2)
2-Hydroxy-2,4-pentadienoate (2)
2-Hydroxymalonate (2)
2-Isopropylmaleate (2)
2-Methylcitrate (2)
2-Oxobutanoate (2)
2-Oxoglutaramate (2)
2-Oxoglutarate (2)
2-Phenylacetamide (2)
3,5/4-Trihydroxycyclohexa-1,2-dione (2)

IsPrivate

False (1)

First Public Date

2024 (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

Transcription profiling by array (29)
RNA-seq of coding RNA (13)
Cell line - High-throughput sequencing (4)
ChIP-chip by tiling array (3)
Comparative genomic hybridization by array (2)
DNA-seq (2)
Human - High-throughput sequencing (1)
RIP-seq (1)
Other (1)
ChIP-seq (1)
Methylation profiling by array (1)

Release Date

2025 (273)
2022 (264)
2021 (256)
2024 (248)
2023 (241)
2020 (208)
2019 (186)
2018 (156)
2017 (113)
2016 (99)
2015 (92)
2014 (78)
2013 (59)
2011 (55)
2012 (52)
2010 (45)
2026 (43)
2009 (36)
2008 (32)
2007 (17)
2005 (8)
2004 (5)
2003 (5)
2006 (4)
1998 (4)
2002 (3)
2000 (2)
2001 (1)
1999 (1)

Lab affiliation

Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (7)
Deputy Head (Research), Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Infection and Immunity Program Room 214, level 2, 15 Innovation Walk Monash Biomedicine Discovery Institute Monash University, Clayton Campus Clayton 3800 Victoria Australia (3)
The University of Sydney (3)
Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800 Australia (2)
Leeds Institute of Medical Research (LIMR) St James's University Hospital Leeds LS9 7TF United Kingdom (2)
1 Department of Biochemistry and Molecular Biology, Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Clayton 3800, Australia. (1)
1 Hudson Institute of Medical Research, Clayton, VIC, Australia, 2 Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia (1)
1. Monash Proteomics and Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia 2. School of Clinical Sciences, Department of Medicine, Monash University, Clayton, Victoria, Australia (1)
Biologics R&D Group/ Biomedical Program CSIRO Manufacturing Bayview Ave/ Research Way, Clayton, VIC3168 Australia (1)
Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton VIC 3800, Australia (1)
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia. (1)
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia (1)
Clayton Foundation Laboratories for Peptide Biology The Salk Institute for Biological Studies 10010 North Torrey Pines Road La Jolla, CA, USA (1)
Core facility for mass spectrometry and proteomics ZMBH, University Heidelberg Im Neuenheimer Feld 282 D-69120 Heidelberg (1)
Daniela Loessner, daniela.loessner@monash.edu, Department of Chemical and Biological Engineering, Faculty of Engineering, Monash University, Clayton, Australia (1)
Department of Anatomy and Developmental BiologyMonash University, Clayton, Victoria, Australia; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. Alexander N Combes alex.combes@monash.edu. David J Nikolic-Paterson david.nikolic-paterson@monash.edu. (1)
Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Infection and Immunity Program Monash Biomedicine Discovery Institute Monash University, Clayton Campus Clayton 3800 Victoria Australia (1)
Department of Biochemistry and Molecular Biology and the Biomedicine Discovery Institute; Monash University; Clayton 3800; Victoria; Australia (1)
Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton 3800 Victoria, Australia. (1)
Department of Biochemistry and Molecular Biology, Infection and Immunity theme, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia (1)
Department of Biochemistry, Monash University, Clayton,3168, Australia (1)
Department of Medicine, Faculty of Medicine, McGill University (1)
Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia. Pok Man Leung, pok.leung@monash.edu, Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia Ralf B. Schittenhelm, ralf.schittenhelm@monash.edu, Monash Proteomics and Metabolomics Facility and Department of Biochemistry, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia (1)
Department of Microbiology, Monash University, Clayton, Victoria, Australia (1)
Head, Translational Antigen Discovery Lab Department of Medicine/ School of Clinical Sciences at Monash Health Monash University Level 7, TRF Building, Monash Medical Centre 246 Clayton Road Clayton VIC 3168 Australia M: +61 415126562 (1)
Icahn School of Medicine at Mount Sinai (1)
Infection & Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia (1)
Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia (1)
Leeds Institute of Medical Research (LIMR) St James's University Hospital Leeds LS9 7TF (1)
Monash Biomedicine Discovery Institute Department of Biochemistry and Molecular Biology Monash University Level 1, Building 77, Clayton Campus 23 Innovation Walk Clayton VIC 3800 Australia (1)

2665 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

First Public Date

Modelling Approach

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets